Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Targeting the toll-system in cardiovascular sciences.

Gábor Földes¹, Stephan von Haehling, Ewa A Jankowska

¹1st Department of Medicine, Semmelweis University, Budapest, Hungary. foldesg@bel1.sote.hu

Recent Patents on Inflammation & Allergy Drug Discovery

|December 17, 2008

Summary

Toll-like receptors (TLRs), crucial for innate immunity, link inflammation to cardiovascular diseases like atherosclerosis. Understanding TLR signaling advances diagnostics and therapies for these conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of iron deficiency on left ventricular noninvasive myocardial work indices in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation.

Cardiology journal·2026

Same author

Endothelial defects unveil cardiovascular phenotype in iPSC-based disease modelling across three generations of a DiGeorge syndrome family.

Research square·2025

Same author

Melt electrowritten medium chain length polyhydroxyalkanoate cardiac patches for Post-MI cardiac regeneration.

Materials today. Bio·2025

Same author

SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI.

ESC heart failure·2025

Same author

Too Late to Turn Back Now? Another Win for Transferrin Saturation: Exercise Parameters and Prognosis in HFpEF.

JACC. Heart failure·2025

Same author

Usefulness of the C<sub>2</sub>HEST score in predicting the clinical outcomes of COVID-19 in obese and non-obese cohorts - subanalysis of the COLOS Study.

Advances in medical sciences·2025

Area of Science:

Immunology
Cardiovascular Medicine

Background:

Toll-like receptors (TLRs) are pattern recognition receptors vital to the innate immune system.
TLRs orchestrate the initial defense against pathogens and tissue damage, linking innate immunity to various clinical disorders.
TLR-mediated inflammation is implicated in cardiovascular diseases, including atherosclerosis, heart failure, viral myocarditis, and diabetic angiopathies.

Purpose of the Study:

To elucidate the molecular basis of Toll-like receptor (TLR) signaling.
To review novel inventions and drug targets within the TLR system for cardiovascular disease treatment.

Main Methods:

Review of scientific literature on TLR signaling pathways.
Analysis of current research on TLRs in the context of cardiovascular pathology.

More Related Videos

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow

Published on: March 14, 2021

Related Experiment Videos

Last Updated: Jun 27, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow

Published on: March 14, 2021

Identification of emerging diagnostic methods and therapeutic compounds.

Main Results:

Detailed description of TLR signaling cascades.
Identification of key TLR ligands and their roles in disease.
Overview of diagnostic and therapeutic compounds in clinical development for cardiovascular applications.

Conclusions:

Enhanced understanding of TLRs offers new avenues for diagnosing and treating cardiovascular diseases.
TLR-targeting therapies represent a promising frontier in cardiovascular medicine.
Continued research into TLRs is crucial for developing innovative treatments for inflammatory cardiovascular conditions.